Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality

BACKGROUND AND AIMS: Patients with severe coronavirus disease 2019 (COVID‐19) are at significant risk of thrombotic complications. However, their prothrombotic state is incompletely understood. Therefore, we measured in vivo activation markers of hemostasis, plasma levels of hemostatic proteins, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Pract Thromb Haemost
Autors principals: von Meijenfeldt, Fien A., Havervall, Sebastian, Adelmeijer, Jelle, Lundström, Annika, Rudberg, Ann‐Sofie, Magnusson, Maria, Mackman, Nigel, Thalin, Charlotte, Lisman, Ton
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles ‐ Thrombosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7845083/
https://ncbi.nlm.nih.gov/pubmed/33537537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12462
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars